The delayed consequences of fetal and neonatal pathology are much more difficult to measure than their immediate influence on mortality. Those who die in late infancy or early childhood and, potentially, those whose congenital handicap is an anatomical one visible at, or soon after, birth are countable. However, many other congenital disorders (for example, cerebral palsy and deafness) cannot be diagnosed in early infancy.
The supposition that toxaemia or antepartum haemorrhage may be either major or contributory causes of neurological and behavioural disorders in childhood derives principally from the knowledge that perinatal mortality is high in both those maternal conditions. As yet, however, the mechanism of death is not fully understood (Buck, 1967; Baird and Thomson, 1969) , although the presence of prematurity may well be a factor in some cases. Among infants surviving a toxaemic pregnancy there is certainly thought to be a possibility of residual damage, particularly to the central nervous system. The studies of Lilienfeld and Pasamanick (1954) and of Lilienfeld, Pasamanick, and Rogers (1955) in Baltimore and New York State, based upon careful retrospective comparisons of brain-damaged and normal children, implicate a number of obstetric complications-in particular, toxaemia and antepartum haemorrhage (Pasamanick and Knobloch, 1959) . It is not yet certain, however, whether either of these complications exerts its effect in the absence of prematurity or of the other complications of pregnancy or labour with which they are frequently associated.
Existing evidence in favour of an association between childhood neuropsychiatric disorder and toxaemia or antepartum haemorrhage derives almost entirely from case history studies. In such studies 'brain-damaged' children are categorized by their similarity in respect of several simultaneously presenting manifestations of illness, and then a history is taken of their frequency of exposure to toxaemia and antepartum haemorrhage. A comparable group of children without the disease is studied in a similar way. However, setting limits of a disease entity such as brain damage on a manifestational basis is a highly complex and, in part, an intuitive procedure, and from the outset considerable confusion has resulted from the use of this term. In particular, there is little doubt that brain damage is much more likely to be diagnosed among infants who are found to have a history of an abnormal pregnancy or birth than among those who have not (Birch, 1964) , thus condemning the findings of retrospective (case history) studies.
The study reported in this paper has attempted to avoid this dilemma by following up a cohort of infants, who experienced toxaemia or antepartum haemorrhage during pregnancy, until they were 12 months old, at which time a detailed developmental and neurological examination was undertaken together with a similar examination of an equal number of matched controls. The examination was undertaken 'blind', i.e., the identity of the subjects (cases and controls) was not known to the examiner.
MATERIALS AND METHODS
Since 1963 the obstetric history of every child born in Cardiff has been fully documented as part of the on-going Cardiff Birth Survey. Thus infants whose mothers experienced toxaemia and/or third-trimester bleeding in this group were easily identified. (Gesell and Amatruda, 1941; Knobloch and Pasamanick, 1962; Roberts, 1968 them in the appropriate section of the schedule. The recorder also informed the examiner when behavioural observations had been omitted, and checked on the completeness of the recording throughout the test procedure.
RESULTS
The incidence of toxaemia and antepartum haemorrhage in the total birth population for the area over the period of the study was 9-2 per 100 births. Ofthe 193 mothers who experienced toxaemia and/or antepartum haemorrhage, 66 % experienced toxaemia alone, 29 % antepartum haemorrhage alone, and 5 % a combination of both. A x2 analysis of observed and expected incidence rates of toxaemia and antepartum haemorrhage occurring together in the same pregnancy gave P < 01001, suggesting that their association is not likely to be one of chance.
There was no evidence that the delivery experience of the cases differed significantly from that of the controls. Twelve per cent of cases weighed less than 5i lb at birth compared with 6% of controls (P <0-003), and 11-5 % of cases were gestationally immature (i.e., <38 weeks) compared with 4-1 % of controls (P < 0-008). Although there were twice as many low birth weight babies among the cases the difference is believed to be due to an excess of gestationally immature infants in the case group and will be explored in a subsequent paper.
The mean aggregate and subscale developmental quotients among the cases and the controls are shown in Table I ; each case subscale score is lower than the equivalent score in the controls, but all are within twice the standard error of the mean, and thus the difference is not statistically significant. A correlation matrix analysis of the interrelation between the aggregate and subscale developmental quotients of both cases and controls was undertaken in order to compare internal consistency: none of the paired comparisons of the 30 correlation coefficients calculated (15 in the case group and 15 Taking the approximate frequencies of severe subnormality to be 004 %, of cerebral palsy 0-01 %, of congenital deafness 0-01 %, and of minimal cerebral damage 002 %, prospective studies of disorders such as these would require sample sizes so large that only relatively simple investigations, such as questionnaires administered by lay observers, could be employed.
The particular question of the relationship between obstetric complications and fetal neurological disorder therefore raises two difficult problems:
(1) The qualitative nature of the mental disorder will usually require a complex and specialized investigative procedure for its accurate determination for survey purposes; and, when the condition sought for has an expectancy of only 0-01 %, it is essential that no cases are missed. Both these considerations demand examination of the sample by a trained specialist.
(2) The only way of making sure that the assessment is administered to a sufficiently large sample to ensure enough cases to determine accurate incidence rates is to employ a large number of observers.
When the information collected is qualitative, or needs a subjective interpretation by the observer, the problem of observer variation is magnified. This need conflicts directly with (1) above.
In view of these difficulties it is improbable that knowledge of the influence of obstetric complications on paediatric neurological disorder can be furthered by a prospective study of whole birth populations. One further possibility remains, namely to increase the likely yield of neurological disorder by selecting a group (or groups) of infants who, from the experience of previous surveys, are thought likely to have a higher expectancy of disorders, and to match them with randomly selected 'controls' from the same section of the population. This is the method used in this study.
When what are generally considered to be highrisk categories were chosen it was somewhat surprising to find that the yield of neurological disorder among cases still remained very low. This observation must almost certainly dismiss a causal association between toxaemia and antepartum haemorrhage and fetal neurological damage. However, the possibility that toxaemia and antepartum haemorrhage may play an intermediate role in a causative chain of events still warrants consideration. If toxaemia and antepartum haemorrhage are harmful only to fetuses already 'predisposed' to suffer damage, the frequency of their association with fetal damage would be limited to those occasions on which the 'predisposing' factor is also present. This hypothesis might explain the low attack rate of neurological disorder recorded among cases in the present study. Some support for this suggestion derives from the findings presented in Table III , which shows the relative risk of neurological abnormality combined with an aggregate developmental quotient of more than one standard deviation below the mean among cases by certain categories of obstetric experience. Although the numbers on which the risk rates have been calculated are small and only the risk rate difference between all cases and all controls is statistically significant, there is nevertheless a suggestion that the associated risk increases as the pregnancy and birth become more complicated. Whether each complication completes a link in the causal chain complex, or whether one complication, in particular, is a vital primary predisposing factor, is unknown. Further studies of the neurological outcome of fetal cohorts categorized by their experience of different groups of multiple obstetric complications (e.g., as in Table 111 ) might help to answer this problem.
Finally, an important gap in our knowledge concerns the role of gestational immaturity in infant morbidity. It is generally accepted as the most important factor in perinatal mortality and is the essential lethal factor in toxaemia and antepartum haemorrhage. It may, however, also be a vital link in the association between toxaemia and antepartum haemorrhage and infant neurological disorder.
SUMMARY
The results of a study of the manifestations of cerebral dysfunction in a cohort of 1-year-old infants who experienced toxaemia and/or antepartum haemorrhage during the associated pregnancy are presented in this paper.
In order to equate the confficting demands posed by, on the one hand, the low attack rate of paediatric mental disorder, which thus requires large study populations in order to ensure stable incidence rates, and, on the other, the problems of observer variation, a two-tier approach was used with one observer only, in which the likely yield of neurological disorder was increased by selecting a group of infants who seemed likely (from previous study) to show a raised expectation of neurological disorder. The mean aggregate and subscale developmental quotients of infants whose mothers experienced toxaemia/antepartum haemorrhage were lower than those of matched controls. The difference is not statistically significant. The frequency of neurological abnormality was increased five-fold among cases compared with controls (P < 0 02). However, the increased frequency of neurological abnormality and developmental delay among cases did not appear to be an expression of a general influence of toxaemia/antepartum haemorrhage throughout the whole sample. There was a suggestion that the relative risk of infant neurological disorder following toxaemia/antepartum haemorrhage was related, in some way, to the presence of certain other obstetric complications-in particular, gestational immaturity.
The possible role oftoxaemia/antepartum haemorrhage in the causal complex of paediatric neurological disorder is briefly discussed. 
